We are live on
!
Find out more
SCM
Shelton Capital Management Portfolio holdings
AUM
$4.57B
1-Year Est. Return
32.26%
This Fund
S&P 500
This Quarter
Est. Return
+10.16%
1 Year Est. Return
+32.26%
3 Year Est. Return
+110.31%
5 Year Est. Return
+153.06%
10 Year Est. Return
+630.09%
AUM
$661M
AUM Growth
+$63.6M
(+11%)
Cap. Flow
+$8.57M
Cap. Flow
% of AUM
1.3%
Top 10 Holdings %
Top 10 Hldgs %
16.59%
Holding
777
New
87
Increased
152
Reduced
160
Closed
27
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Axos Financial
AX
|
+$1.14M |
| 2 |
Intercontinental Exchange
ICE
|
+$1.1M |
| 3 |
Exelixis
EXEL
|
+$1.1M |
| 4 |
Tesla
TSLA
|
+$1.09M |
| 5 |
Intel
INTC
|
+$582K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
BioMarin Pharmaceuticals
BMRN
|
+$3.57M |
| 2 |
FLG
Flagstar Bank National Association
FLG
|
+$1.62M |
| 3 |
CELG
Celgene Corp
CELG
|
+$1.59M |
| 4 |
Vertex Pharmaceuticals
VRTX
|
+$1.54M |
| 5 |
Ametek
AME
|
+$1.25M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.89% |
| 2 | Healthcare | 15% |
| 3 | Financials | 12.41% |
| 4 | Industrials | 10.23% |
| 5 | Energy | 8.65% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
126
Novartis
NVS
$290B
| $1.08M | 0.16% |
15,018
| – | – |
|
127
Wolfspeed
WOLF
$1.65B
| $1.07M | 0.16% |
17,091
+1,651
| +11% | +$102K |
|
|
SFG
128
DELISTED
STANCORP FINL GRP
SFG
| $1.06M | 0.16% |
16,011
-274
| -2% | -$16.9K |
|
|
COL
129
DELISTED
Rockwell Collins
COL
| $1.06M | 0.16% |
14,279
+800
| +6% | +$56.8K |
|
130
Baidu
BIDU
$35.3B
| $1.05M | 0.16% |
5,919
| – | – |
|
|
BNY
131
Bank of New York Mellon
BNY
$111B
| $1.05M | 0.16% |
30,142
| – | – |
|
132
Polaris
PII
$3.89B
| $1.02M | 0.15% |
7,009
-153
| -2% | -$20.5K |
|
133
Church & Dwight Co
CHD
$24.2B
| $1.02M | 0.15% |
30,698
| – | – |
|
134
iShares Core US Aggregate Bond ETF
AGG
$138B
| $1.01M | 0.15% |
9,511
-40
| -0.4% | -$4.29K |
|
135
FedEx
FDX
$77B
| $1M | 0.15% |
6,978
| – | – |
|
|
XEC
136
DELISTED
CIMAREX ENERGY CO
XEC
| $993K | 0.15% |
9,468
-188
| -2% | -$19K |
|
|
LPS
137
DELISTED
LENDER PROCESSING SERVICES INC
LPS
| $991K | 0.15% |
26,522
| – | – |
|
138
DuPont de Nemours
DD
$19.4B
| $982K | 0.15% |
8,738
+4,462
| +104% | +$457K |
|
139
Trimble
TRMB
$13.3B
| $973K | 0.15% |
28,034
| – | – |
|
140
KLA
KLAC
$272B
| $961K | 0.15% |
149,050
+2,000
| +1% | +$12.6K |
|
141
Mohawk Industries
MHK
$9.21B
| $958K | 0.14% |
6,435
| – | – |
|
142
NiSource
NI
$20.2B
| $955K | 0.14% |
73,932
-1,018
| -1% | -$12.6K |
|
143
3D Systems Corp
DDD
$605M
| $945K | 0.14% |
10,164
| – | – |
|
144
Applied Materials
AMAT
$437B
| $944K | 0.14% |
53,348
+14,899
| +39% | +$260K |
|
145
MetLife
MET
$61.5B
| $944K | 0.14% |
19,639
+4,375
| +29% | +$196K |
|
|
BEAV
146
DELISTED
B/E Aerospace Inc
BEAV
| $938K | 0.14% |
14,890
-1,280
| -8% | -$76.4K |
|
147
Oceaneering
OII
$5.04B
| $934K | 0.14% |
11,843
-167
| -1% | -$13.6K |
|
|
KRFT
148
DELISTED
KRAFT FOODS GROUP INC COM STK (VA)
KRFT
| $932K | 0.14% |
17,286
+498
| +3% | +$26.6K |
|
149
Rogers Communications
RCI
$19.1B
| $911K | 0.14% |
20,140
| – | – |
|
150
SL Green Realty
SLG
$3.98B
| $905K | 0.14% |
10,125
| – | – |
|
Similar funds
SV
LNWTC
VCM
ACM
JRP
MA
GIBU
EI
Shelton Capital Management's Q4 2013 Portfolio in Review
As of Q4 2013, Shelton Capital Management held 777 positions worth $661M, up 11% from $598M the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Shelton Capital Management's Q4 2013 filing shows 87 new, 152 increased, 160 reduced and 27 closed positions. Its largest new stake was Axos Financial: 63,596 shares worth $1.25M. The largest sale was BioMarin Pharmaceuticals, an estimated $3.57M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Healthcare and Financials.
- Shelton Capital Management's largest Q4 2013 buy was Axos Financial: 63,596 shares worth $1.25M.
- Shelton Capital Management added most to Tesla in Q4 2013, an estimated $1.09M increase.
- Shelton Capital Management's biggest Q4 2013 reduction was BioMarin Pharmaceuticals, cutting an estimated $3.57M.
- Shelton Capital Management fully exited Ametek in Q4 2013, selling an estimated $1.25M.
- Shelton Capital Management's ten largest holdings make up 17% of its $661M portfolio in Q4 2013.
- Shelton Capital Management opened 87 new positions and closed 27 in Q4 2013.
- Shelton Capital Management's portfolio value rose 11% quarter-over-quarter to $661M.
Based on Shelton Capital Management's 13F filing for Q4 2013, filed 22 Jan 2014.